Ensayos Clínicos

Ensayos Clínicos

• Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients.
  Duración: 2012 hasta actualidad.
   
• D3820C00016. A Phase I, Open label, Multicentre Study to Assess the Pharmacokinetics and Safety of Naloxegol in Paediatric Patients Ages > 6 Months to < 18 Years receiving Treatment  with Opioids.
  Duración:  2014 hasta actualidad.
   
• XM22-08. An opened labeled randomized active-control multicenter study to evaluate the efficacy, pharmacokinetics, pharmacodynamics safety tolerability and immunogenicity of lipegfilgrastim 100 mcg/Kg body weight in comparation to filgrastim 5 mcg/Kg body weight in pediatric patients diagnosed with Ewing family of tumors or rhabdomyosarcoma receiving chemotherapy. Phase II. 
  Duración: Desde 2015 hasta actualidad.
   
• A three month prospective open label study of therapy with fragmin (registered) (dalteparin sodium injection) in children with venous thromboembolism with or without malignancies. 
  Duración: desde Enero 2017 hasta actualidad.
   
• LOXO-TRK-15002. A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors.
  Duración: Desde 2016 hasta actualidad.